New study published in The Journal of Neuroscience highlights disease-modifying potential of Neurodon’s SERCA activators for Alzheimer’s disease Read More
Neurodon CEO Dr. Russell Dahl to Present at the 20th FASEB Conference on Calcium and Cell Function Read More
Accomplished Biotech Executive Frederick Beddingfield III, M.D., Ph.D. Joins Neurodon’s Board Read More
JDRF and Neurodon Partner to Advance Small Molecules Targeting a Key Pathway in Type 1 Diabetes Progression Read More